Neurology: Disease Deep Dive

1-12 of 12

• 

  RestartResume

  Part I: Early Alzheimer Disease Detection with the DAC-SP Blueprint Program: Overview of a Scalable Health System Approach

  RestartResume

  Part I: Early Alzheimer Disease Detection with the DAC-SP Blueprint Program: Overview of a Scalable Health System Approach

  Alzheimer Disease & Dementias

  Part I: Early Alzheimer Disease Detection with the DAC-SP Blueprint Program: Overview of a Scalable Health System Approach

  Elyse Perweiler, RN, MPP; Tim MacLeod, PhD

  Elyse Perweiler, RN, MPP; Tim MacLeod, PhD

• 

  RestartResume

  Detecting Multiple Sclerosis Earlier: PRLs and the Evolving McDonald Diagnostic Criteria

  RestartResume

  Detecting Multiple Sclerosis Earlier: PRLs and the Evolving McDonald Diagnostic Criteria

  MS & Immune Disorders

  Detecting Multiple Sclerosis Earlier: PRLs and the Evolving McDonald Diagnostic Criteria

  Daniel Ontaneda, MD, PhD; Pascal Sati, PhD

  Daniel Ontaneda, MD, PhD; Pascal Sati, PhD

• 

  RestartResume

  Modern Glioma Management: Integrating Molecular Markers and New Targeted Therapies

  RestartResume

  Modern Glioma Management: Integrating Molecular Markers and New Targeted Therapies

  Neuro-oncology

  Modern Glioma Management: Integrating Molecular Markers and New Targeted Therapies

  Patrick Y. Wen, MD

  Patrick Y. Wen, MD

• 

  RestartResume

  Maturing with Migraine: Practical Guidelines for Transitioning Adolescent Migraine and Headache Patients into Adult Practice

  RestartResume

  Maturing with Migraine: Practical Guidelines for Transitioning Adolescent Migraine and Headache Patients into Adult Practice

  Headache & Pain

  Maturing with Migraine: Practical Guidelines for Transitioning Adolescent Migraine and Headache Patients into Adult Practice

  Hope O'Brien, MD, MBA, FAHS, FAAN

  Hope O'Brien, MD, MBA, FAHS, FAAN

• 

  RestartResume

  Advances in ALS: New Targets, Trials, and Care Strategies

  RestartResume

  Advances in ALS: New Targets, Trials, and Care Strategies

  Neuromuscular

  Advances in ALS: New Targets, Trials, and Care Strategies

  Merit Cudkowicz, MD, MSc

  Merit Cudkowicz, MD, MSc

• 

  RestartResume

  Cerebrovascular Inflammatory Conditions: Diagnostic Challenges and Treatment Considerations

  RestartResume

  Cerebrovascular Inflammatory Conditions: Diagnostic Challenges and Treatment Considerations

  Stroke

  Cerebrovascular Inflammatory Conditions: Diagnostic Challenges and Treatment Considerations

  Abbas Kharal, MD, MPH

  Abbas Kharal, MD, MPH

• 

  RestartResume

  The Evolving Therapeutic Landscape for Parkinson Disease

  RestartResume

  The Evolving Therapeutic Landscape for Parkinson Disease

  Movement Disorders

  The Evolving Therapeutic Landscape for Parkinson Disease

  Mark Stacy, MD

  Mark Stacy, MD

• 

  RestartResume

  Advances in the Evaluation of TBI

  RestartResume

  Advances in the Evaluation of TBI

  TBI

  Advances in the Evaluation of TBI

  Beth McQuiston, MD, RD; David Okonkwo, MD, PhD

  Beth McQuiston, MD, RD; David Okonkwo, MD, PhD

• 

  RestartResume

  NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies

  RestartResume

  NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies

  MS & Immune Disorders

  NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies

  Derrick Robertson, MD

  Derrick Robertson, MD

• 

  RestartResume

  NMOSD Part 2 - The importance and tools for monitoring NMOSD, and signs, symptoms and evaluation of disease activity

  RestartResume

  NMOSD Part 2 - The importance and tools for monitoring NMOSD, and signs, symptoms and evaluation of disease activity

  MS & Immune Disorders

  NMOSD Part 2 - The importance and tools for monitoring NMOSD, and signs, symptoms and evaluation of disease activity

  Derrick Robertson, MD

  Derrick Robertson, MD

• 

  RestartResume

  NMOSD Part 1 - Overview and important considerations for diagnosis

  RestartResume

  NMOSD Part 1 - Overview and important considerations for diagnosis

  MS & Immune Disorders

  NMOSD Part 1 - Overview and important considerations for diagnosis

  Derrick Robertson, MD

  Derrick Robertson, MD

• 

  RestartResume

  Narcolepsy, Idiopathic Hypersomnia, and General Sleep Disorders

  RestartResume

  Narcolepsy, Idiopathic Hypersomnia, and General Sleep Disorders

  Sleep

  Narcolepsy, Idiopathic Hypersomnia, and General Sleep Disorders

  Rajkumar Dasgupta, MD

  Rajkumar Dasgupta, MD